Microbot Medical announced that it has expanded its global presence to South America with the addition of Francisco C. Carnevale, MD, PhD, FSIR, becoming the latest key opinion leader to join the Company’s Scientific Advisory Board. With the addition of Dr. Carnevale to its SAB, the Company now has 13 KOLs on its SAB, including seven from the U.S., three in Israel, two from EU nations, and Dr. Carnevale representing the first from Brazil, all with a singular focus of supporting the regulatory and commercial paths for the LIBERTY Robotic System. Dr. Carnevale, a vascular and interventional radiologist based in Sao Paolo, Brazil, is the Chief of the Vascular Interventional Radiology Section at Hospital das Clinicas – University of Sao Paulo Medical School Hospital.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MBOT:
- Microbot Medical Meeting with Key Opinion Leaders, Hospital Administrators, and Potential Strategic and Commercial Partners at the Society of Interventional Radiologist Annual Meeting
- Microbot Medical recieves Japan patent allowace for LIBERTY remote controller
- Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next “Access-Ability Live by MBOT” Webinar Series
- Microbot Medical Announces MedTech Industry Veteran Joe Mullings will Moderate the Next ‘Access-Ability Live by MBOT’ Webinar
